Key facts
- This page summarizes Jeffrey M. Fryer's Form 4 filing for Rallybio Corp (RLYB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Mar 2022, 17:30.
Jeffrey M. Fryer - 21 Mar 2022 Form 4 Insider Report for Rallybio Corp (RLYB)
- Reporting relationship
- Chief Financial Officer & Treasurer
- Issuer ticker
- RLYB
- Reported as of
- 21 Mar 2022
- Net transaction value
- +$24,120
- SEC form
- 4
- Accepted by SEC
- 23 Mar 2022, 17:30:12 UTC
- Prior SEC filing
- 09 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Michael Greco, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey M. Fryer filed Form 4 for Rallybio Corp (RLYB) on 23 Mar 2022.
Change
- Previous filing in this sequence was filed on 09 Feb 2022.
- Current net transaction value: +$24,120.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RLYB
transaction
Common Stock
Purchase
- Transaction value
- $24,120
- Shares
- +3,000
- Change %
- +6.8%
- Price
- $8.04
- Shares after
- 47,048
- Date
- 21 Mar 2022
- Ownership
- See Footnote
- Footnotes
- F1, F2
RLYB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 272,609
- Date
- 21 Mar 2022
- Ownership
- See Footnote
- Footnotes
- F3
RLYB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 201,934
- Date
- 21 Mar 2022
- Ownership
- See Footnote
- Footnotes
- F4
RLYB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 201,934
- Date
- 21 Mar 2022
- Ownership
- See Footnote
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.99, inclusive. The reporting person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
Footnote F2
Shares of common stock are held in a Roth IRA.
Footnote F3
Shares of common stock are held in a revocable trust for which Mr. Fryer is the grantor.
Footnote F4
Shares of common stock are held in an irrevocable trust for the benefit of one of Mr. Fryer's children. Mr. Fryer disclaims beneficial ownership of such shares.
Footnote F5
Shares of common stock are held in an irrevocable trust for the benefit of one of Mr. Fryer's children. Mr. Fryer disclaims beneficial ownership of such shares.
SEC remarks
Chief Financial Officer & Treasurer